| 2026-01-26 | Ai-Drug-Discovery | AI-driven drug discovery and repurposing using multi-omics for myocardial infarction and heart failure. | Exploration of medicine | 60.7 | PMID, DOI |
| 2026-01-26 | Ai-Drug-Discovery | Explainable artificial intelligence for molecular design in pharmaceutical research. | Chemical science | 59.7 | PMID, DOI |
| 2026-01-26 | Ai-Drug-Discovery | Artificial Intelligence and Machine Learning in Antimicrobial Discovery, Resistance Prediction, and Precision Therapy. | International journal of antimicrobial agents | 58.1 | PMID, DOI |
| 2026-01-26 | De-Novo-Protein-Design | Data-driven de novo design of super-adhesive hydrogels. | Nature | 74.5 | PMID, DOI |
| 2026-01-26 | De-Novo-Protein-Design | Integrated biotechnological and AI innovations for crop improvement. | Nature | 71.2 | PMID, DOI |
| 2026-01-26 | De-Novo-Protein-Design | Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovation. | International journal of pharmaceutics | 70.0 | PMID, DOI |
| 2026-01-27 | Ai-Drug-Discovery | Artificial intelligence in human immunodeficiency virus mutation prediction and drug design: Advancing personalized treatment and prevention. | Pharmaceutical science advances | 59.0 | PMID, DOI |
| 2026-01-31 | Ai-Drug-Discovery | Machine learning for drug-target interaction prediction: A comprehensive review of models, challenges, and computational strategies. | Computational and structural biotechnology journal | 58.5 | PMID, DOI |